Are you a CIPA member?
Sign in to your account to register for the event
If you are not yet registered or a member of CIPA, please register here
- News
- News
- NewsMedia
- Events
- Events
- EventsIntroductory Patent Paralegal CourseAdvanced Patent Paralegal Course (APPC)
- Advice
- Advice
- IP explainedResources
- Members
- Members
- MembershipBrand & Marketing Materials
- Publications
- Publications
- Online ShopCIPA JournalDownloads
- Jobs
- About Us
×Event Listing
SPCs for plant protection products after Brexit – what’s the same and what’s different
18Jun
Webinar SPCs for plant protection products after Brexit – what’s the same and what’s different
Thursday 18 June
Location
In this webinar we will shine the spotlight on Supplementary Protection Certificates (SPCs) for plant protection products (PPPs), explaining how these products are authorised in the UK and European Union and what this means for the process of obtaining SPCs. We will cover the differences and similarities between SPCs for PPPs and their more numerous medicinal product counterparts. We will also discuss the extent to which case law of the Court of Justice of the European Union is relevant to SPCs for PPPs and some other noteworthy developments in the field of which practitioners need to be aware.
Audience
All
Speakers
Joel Beevers, Potter ClarksonJoel Beevers, Potter Clarkson
Dr Joel Beevers is a UK and European Patent Attorney in Potter Clarkson’s Nottingham team. After obtaining degrees in biochemistry and neuroscience, Joel was awarded a DPhil for his research in stem-cell derived neuronal models of Parkinson’s disease. Joel’s professional practice spans the life science sector, with particular specialism in drafting and prosecuting patent filings in biotechnology and in handling and advising on SPCs and regulatory exclusivities. Joel is also a member of CIPA’s Life Sciences Committee and the editor of the chapter on biological inventions in the European Patents Handbook.
Lawrence Cullen, Independent ConsultantLawrence Cullen, Independent Consultant
Dr Lawrence Cullen established his own consultancy, Lawrence Cullen@ConsultingIP, in 2025 to pursue his interests in biotechnology and in the role and relevance of SPCs. He is also a visiting scholar at the School of Law, University of Sheffield where he is collaborating on some research projects in IP and biotechnology. Dr Cullen was a Deputy Director at the Intellectual Property Office (IPO) in the UK from 2007 to 2024 where he had responsibility for operational delivery of SPCs and for patents in the pharma, organic chemistry and biotech fields. He joined the IPO in 1997 as a patent examiner in chemistry and worked in a variety of operational, technical and policy roles in patents and trademarks before taking on the Deputy Director role. Dr Cullen has a wide experience as a hearing officer dealing with questions of validity and patentability, having been involved in over 50 patent and over 25 SPC cases before the IPO and subsequent appeals before the UK courts and, prior to 2021, the Court of Justice of the European Union (CJEU). He has also worked as a hearing officer adjudicating trademark disputes. Dr Cullen was educated in chemistry in Ireland and the UK and worked as a research scientist at various universities in Europe and USA before joining the IPO.
Shopping Bag (0)